Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03842228 |
|---|---|
| Brief Title: | Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations |
| First Submitted : | February 7, 2019 |
| First Submitted that Met QC Criteria : | February 13, 2019 |
| First Posted : | February 15, 2019 |
| Last Update Submitted that Met QC Criteria : | January 4, 2022 |
| Last Update Posted : | January 5, 2022 |